TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
TerminatedN/A

Timing of Coronary Angiography in NSTE-ACS With ADHF

The investigators hypothesized that immediate coronary angiography (CAG) within 2 hours after admission can reduce mortality compared to delayed CAG after stabilization of acute decompensated heart failure (ADHF) in patients with non-ST-seg

Gwangju, South KoreaView details
CompletedPhase 1 / Phase 2

Atrial Functional Mitral Regurgitation Response In Mitral Loop Cerclage Annuloplasty (AFRICA Study)

To evaluate second stage safety and feasibility of Mitral Loop Cerclage(MLC) Annuloplasty with CSTV for repair of functional mitral regurgitation.

Daegu, Dalseo-gu, South Korea+6 moreView details
Completed

Evaluating the Relationship Between Fatty Acids and Heart Disease

Cardiovascular disease (CVD) affects millions of people in the United States; each year, more people die from CVD than from any other disease. Individuals with low levels of n-3 fatty acids and high levels of trans-fatty acids may have an i

Boston, Massachusetts, United States+3 moreView details
Active, not recruiting

Sepsis in the ICU-II

Sepsis-induced cardiac dysfunction (SIMD) is a well-known phenomenon yet its diagnosis remains elusive with no accepted definition, or defining pathophysiological mechanism associated with this disease. Systolic dysfunction occurs in 20-70%

Dijon, France+3 moreView details
Completed

Prevalence and Dynamic of Sleep-disordered Breathing in Patients Pre and Post Heart Transplantation

Sleep-disordered breathing is believed to appear at a high prevalence in end-stage heart failure patients and the presence of sleep-disordered breathing has been associated with increased mortality. This study is designed to investigate pre

Bad Oeynhausen, North Rhine-Westphalia, GermanyView details
Completed

The Relationship Between Epicardial Fat Tissue and Cardiac Function in HFpEF Patients

Heart failure with preserved ejection fraction (HFpEF) refers to a group of symptoms and signs of heart failure, normal or near-normal left ventricular systolic function (EF\>50%), and ventricular muscle diastolic dysfunction and A clinical

Chongqing, ChinaView details
RecruitingPhase 3

Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure

The EMPA-AHF trial is a multicentre, randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy and safety of early initiation of once-daily oral empagliflozin 10 mg in patients hospitalized for patients with acute

Anjo, Aichi-ken, Japan+68 moreView details
CompletedN/A

Mitral Loop Cerclage(MLC) for Reducing Functional Mitral Regurgitation

To evaluate safety and feasibility of Mitral Loop Cerclage(MLC) Annuloplasty with CSTV for repair of functional mitral regurgitation.

Bethesda, Maryland, United States+1 moreView details
Unknown

Cardiac Cachexia in Advanced Heart Failure

Heart failure is a condition in which the heart stops pumping effectively, causing symptoms such as breathlessness or leg swelling. It affects around 900,000 people in the United Kingdom.

London, United KingdomView details
Unknown

Diagnosis And Treatment of Sleep Apnea in Patient With Heart Failure

DASAP-HF is an observational prospective single arm study. All patients will be treated according to the standard care followed by each center.

Florence, ItalyView details
Not yet recruiting

Left Ventricular Myocardial Work for Predicting Response to CRT

This study aims to establish the normal reference values for left ventricular myocardial work in healthy Chinese adults and the influencing factors. Non-invasive myocardial work serves as a new parameter for identifying CRT responders and p

Hefei, Anhui, China+81 moreView details
CompletedN/A

Teledi@Log - Tele-rehabilitation of Heart Patients

The idea behind the Teledi@log consortium is to develop tele-rehabilitation concepts and technologies so that all types of heart disease patients, regardless of degree of severity, can be offered individual, customized and coordinated tele-

Aalborg, Denmark+1 moreView details
Not yet recruitingN/A

CALM Study: Cardiomems Assisted Lvad Management

This prospective, open label, randomized, single-center pilot clinical trial will determine if the rate of heart failure related (HFR) hospitalizations is less in LVAD patients whose PAP is monitored with the CardioMEMS device vs the contro

Plano, Texas, United StatesView details
Completed

Catecholamine-O-Methyl-Transferase(COMT)-Polymorphism in Cardiac Surgery

Although clinical risk factors for postoperative development of vasodilatory shock and acute renal failure have been identified; there is a considerable proportion of patients undergoing cardiac surgery where this syndrome cannot be predict

Melbourne, Victoria, AustraliaView details
CompletedN/A

Dynamic Variation of Impedance Cardiography(DYVIC) as a Diagnostic Tool of Acute Heart Failure (AHF)

the study aimed to evaluate the diagnostic performance of cardiac output (CO) change after the use of trinitrine in the diagnosis of heart failure patients with acute dyspnea.

Monastir, TunisiaView details
Completed

The Impact of Menopause on the Development of Heart Failure and Organ Damage of Hypertension

Introduction: The average age of menopause in the Polish population is around 50 years. After the occurrence of the last menstruation in the woman's body there are series of hormonal changes that may result in the emergence of new diseases,

Lodz, PolandView details
CompletedPhase 3

Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure

A multicenter, randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the effect of recombinant human Neuregulin-1 for injection on cardiac function and reverse ventricular remodeling in male patients with NT-proB

Beijing, Beijing Municipality, China+102 moreView details
CompletedPhase 2

Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2

REDHART2 is a randomized, double-blinded, placebo-controlled trial to determine the effects of Anakinra on peak aerobic exercise capacity measured with a cardiopulmonary test after 24 weeks in patients with recently decompensated systolic h

Richmond, Virginia, United StatesView details
CompletedPhase 2

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure

This study is being done to compare the effects of bucindolol hydrochloride (bucindolol) to metoprolol succinate (Toprol-XL) on the recurrence of symptomatic atrial fibrillation/atrial flutter in patients with heart failure who have a speci

Anchorage, Alaska, United States+96 moreView details
Recruiting

New Orleans Pulmonary Hypertension Biobank

Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is require

New Orleans, Louisiana, United StatesView details
Load more trials